Search research articles
Contact Us
Filters
Showing results (31-40 of 39) with videos related to
Page
of 4
Sort By:
You have reached the last page of results.
This site can display upto 39 results.
The New England Journal of Medicine
|
December 9, 1976
Control of hepatitis b infection in an institution
M Piazza, L Picciotto, R De Mercato, et al.
Vaccine
|
March 13, 1999
Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme
M Piazza, A Safary, A Vegnente, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
November 30, 1986
[Effect of cocaine administration on experimental hepatitis in the mouse caused by MHV-3 virus: preliminary results]
V Guadagnino, A Chirianni, L Picciotto, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
October 1, 1989
Immunogenicity of a DNA-recombinant hepatitis B vaccine (Engerix B) given at 3, 5 and 11 months of age with a new schedule suitable for mass vaccination programmes
M Piazza, G Da Villa, L Picciotto, et al.
Lancet (London, England)
|
November 12, 1988
Mass vaccination against hepatitis B in infants in Italy
M Piazza, G Da Villa, L Picciotto, et al.
Minerva Stomatologica
|
December 1, 1987
[HBsAg (hepatitis B virus surface antigen) contamination in the dental environment]
M Piazza, G Valletta, L Picciotto, et al.
Lancet (London, England)
|
November 16, 1985
Two-dose hepatitis B immunisation regimen for infants
M Piazza, L Picciotto, R Villari, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
December 1, 1991
Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission
M Piazza, A Chirianni, L Picciotto, et al.
Lancet (London, England)
|
April 27, 1985
Hepatitis B immunisation with a reduced number of doses in newborn babies and children
M Piazza, L Picciotto, R Villari, et al.
Page
of 4
Search research articles
Search
Showing results (31-40 of 39) with videos related to
Sort By:
Page
of 4
You have reached the last page of results.
This site can display upto 39 results.
The New England Journal of Medicine
|
December 9, 1976
Control of hepatitis b infection in an institution
M Piazza, L Picciotto, R De Mercato, et al.
Vaccine
|
March 13, 1999
Safety and immunogenicity of hepatitis A vaccine in infants: a candidate for inclusion in the childhood vaccination programme
M Piazza, A Safary, A Vegnente, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
November 30, 1986
[Effect of cocaine administration on experimental hepatitis in the mouse caused by MHV-3 virus: preliminary results]
V Guadagnino, A Chirianni, L Picciotto, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
October 1, 1989
Immunogenicity of a DNA-recombinant hepatitis B vaccine (Engerix B) given at 3, 5 and 11 months of age with a new schedule suitable for mass vaccination programmes
M Piazza, G Da Villa, L Picciotto, et al.
Lancet (London, England)
|
November 12, 1988
Mass vaccination against hepatitis B in infants in Italy
M Piazza, G Da Villa, L Picciotto, et al.
Minerva Stomatologica
|
December 1, 1987
[HBsAg (hepatitis B virus surface antigen) contamination in the dental environment]
M Piazza, G Valletta, L Picciotto, et al.
Lancet (London, England)
|
November 16, 1985
Two-dose hepatitis B immunisation regimen for infants
M Piazza, L Picciotto, R Villari, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale
|
December 1, 1991
Blood in saliva of HIV seropositive drug abusers: possible implication in AIDS transmission
M Piazza, A Chirianni, L Picciotto, et al.
Lancet (London, England)
|
April 27, 1985
Hepatitis B immunisation with a reduced number of doses in newborn babies and children
M Piazza, L Picciotto, R Villari, et al.
Page
of 4